0001209191-22-001623.txt : 20220105 0001209191-22-001623.hdr.sgml : 20220105 20220105160219 ACCESSION NUMBER: 0001209191-22-001623 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Edwards Martin CENTRAL INDEX KEY: 0001640073 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 22511056 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-03 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001640073 Edwards Martin 5320 LEGACY DRIVE PLANO TX 75024 1 0 0 0 Class A common stock 2022-01-03 4 A 0 59 27.32 A 59 D Stock Option (right to buy) 27.32 2022-01-03 4 A 0 99 16.14 A 2032-01-03 Class A common stock 99 99 D The shares represent Restricted Stock Units (RSU), which vest on June 8, 2022, subject to continued service through the vesting date. These RSUs were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $1,612.50. The options vest in 2 equal installments on March 10, 2022 and June 10, 2022, subject to continued service through each vesting date. These options were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $1,612.50. /s/ Tracy Herson, attorney-in-fact 2022-01-05